Compare CDMOs with GMP microbiology laboratory capabilities for sterility testing, endotoxin analysis, bioburden, and environmental monitoring.
164 companies listed
China
Global CRO specializing in biosafety services for the pharmaceutical industry. Founded in 1987 at the Pasteur Institute in Paris to address HIV safety testing. Provides viral safety, biosafety testing, viral clearance studies, bioassays (in vitro and in vivo), and cell banking services for biologics, cell and gene therapies, and medical devices. Employs 140 people across offices and laboratories in France, US, Germany, China, Taiwan, and Japan. Also recently added BioManufacturing services, though the core business is contract testing/research, not drug manufacturing.
India
Veeda Lifesciences (formerly Veeda Clinical Research) is a tech-driven global CRO headquartered in Ahmedabad, India with presence in 9 countries and sites across 26 geographies. They rebranded in January 2025 and now operate through four Strategic Business Units: Clinical Trials, Healthy Volunteer Services, Biopharma Services, and a fourth unit. Services include pre-clinical research, bioanalytical testing, clinical development for generics/innovators/biotherapeutics, real-world evidence, regulatory affairs, medical writing, pharmacovigilance, and data science. They have 2,100+ employees and are transitioning to a CRO-CDMO model per recent announcements, though their current core business remains contract research. Specializations include hemato-oncology, monoclonal/bispecific/trispecific antibody development, and multiple myeloma trials.
Our AI Matchmaker analyzes your project requirements and matches you with qualified manufacturing partners. Free for buyers.